Overcoming Tumor Heterogeneity by Ex Vivo Arming of T Cells Using Multiple Bispecific Antibodies
This study evaluates multi-antigen targeting strategies using bispecific antibodies to enhance T cell immunotherapy against heterogeneous tumors, showing improved efficacy and reduced cytokine release.
bioRxiv · Aug 31, 2021Cancer Biology